Jeffrey S Mathiesen is of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 86,636 shares of NMTC, which is worth approximately $58,912. The most recent transaction as insider was on Mar 16, 2023, when has been sold 20,576 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.6K
0% 3M change
0% 12M change
Total Value Held $58,912

JEFFREY S MATHIESEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2023
BUY
Grant, award, or other acquisition
-
20,576 Added 19.19%
86,636 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
-
29,240 Added 30.68%
66,060 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
4,592 Added 11.09%
36,811 Common Stock

Also insider at

PBLA
Panbela Therapeutics, Inc. Healthcare
HSDT
HELIUS MEDICAL TECHNOLOGIES, INC. Healthcare
JSM

Jeffrey S Mathiesen

Pleasanton, CA

Track Institutional and Insider Activities on NMTC

Follow NEUROONE MEDICAL TECHNOLOGIES Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC